Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations, as the company temporarily paused shipments of a key vaccine into China. Shares of Merck closed 8 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results